Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03825575

Sacral Neuromodulation as Treatment for Fecal Incontinence

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
6 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to investigate if low level laser therapy will do more good than harm for patients with severe refractory fecal incontinence. It is a proof of concept study without a placebo arm.

Detailed description

The therapy consists of a 3 week treatment with a total of 8 sessions of low level laser therapy. Effects will be assessed using symptoms and quality of life questionnaires and physiological assessments of pelvic floor function, at 4 weeks and 12 weeks after beginning of treatment.

Conditions

Interventions

TypeNameDescription
DEVICELow level laser therapy (LLLT)A 3 week treatment period with a total of 8 treatments of 1 hour over the sacral spinal cord

Timeline

Start date
2019-09-08
Primary completion
2025-02-01
Completion
2027-02-01
First posted
2019-01-31
Last updated
2022-04-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03825575. Inclusion in this directory is not an endorsement.

Sacral Neuromodulation as Treatment for Fecal Incontinence (NCT03825575) · Clinical Trials Directory